• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,025.19 -173.50
(-0.33%)
Dow Jones
7,682.22 -82.84
(-1.07%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,879.96 39.61
(0.37%)
Forex
USD-INR
94.85 -0.23
(-0.24%)
EUR-INR
106.35 0.11
(0.11%)
GBP-INR
125.73 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.07%)

EQUITY - MARKET SCREENER

Makers Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506919
INE987A01010
92.2552664
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MAKERSL
0
122.31
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

uflex ltd
Indo US Bio-Tech standalone net profit declines 46.47% in the March 2026 quarter
Jun 01,2026
Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.

For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales26.0233.38 -22 110.44103.84 6
OPM %12.4113.69 -15.4018.24 -
PBDT2.654.43 -40 14.8217.63 -16
PBT2.383.87 -39 13.9216.53 -16
NP1.973.68 -46 13.1216.27 -19